Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment

Toll-like receptors are potent activators of the innate immune system and generate signals leading to the initiation of the adaptive immune response that can be utilized for therapeutic purposes. We tested the hypothesis that combined treatment with a Toll-like receptor agonist and an antitumor mono...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Shangzi, Astsaturov, Igor A., Bingham, Catherine A., McCarthy, Kenneth M., von Mehren, Margaret, Xu, Wei, Alpaugh, R. Katherine, Tang, Yong, Littlefield, Bruce A., Hawkins, Lynn D., Ishizaka, Sally T., Weiner, Louis M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3517883/
https://ncbi.nlm.nih.gov/pubmed/21842208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-011-1090-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados